Alison W. Loren, MD, MSCE serves as the Chief of the Division of Hematology-Oncology at the Perelman School of Medicine. Dr. Loren is the Director of Blood and Marrow Transplant in the Transplant and Cellular Therapy Program of the Abramson Cancer Center, a clinician in hematologic malignancies, and a Professor of Medicine.
With an extensive portfolio of over 100 peer-reviewed publications, Dr. Alison Loren has established herself as a prominent figure in haematology-oncology. Her focus lies in conducting clinical trials related to hematologic malignancies and allogeneic hematopoietic cell transplantation. Dr. Loren is particularly dedicated to enhancing transplant outcomes and post-transplant survivorship, showcasing expertise in fertility preservation.
Dr. Loren has served as co-Chair of the Regimen Related Toxicity Committee and contributed significantly to the Bone Marrow Transplant Clinical Trials Network (BMT-CTN), including acting as the site Principal Investigator for various trials. Her involvement extends to the American Society of Hematology (ASH), where she currently holds an elected position on the Executive Committee.
Dr. Loren's academic journey includes earning her AB in Biology from Harvard University, completing medical school at Washington University in St. Louis, and undergoing internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania, where she also served as Chief Resident. Further, she completed her subspecialty training in Hematology and Oncology at the University of Pennsylvania, during which she held the position of Chief Fellow. Notably, she earned her Master of Science degree in Clinical Epidemiology from the Center for Clinical Epidemiology and Biostatistics (CCEB) at the University of Pennsylvania.
